Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 6603834904
Loop profile: 303117
SciProfiles: 323455

Keywords

opioid receptors, opioid ligands, pain, GPCRs, opioid pharmacology, signaling, drug disco

Countries

Austria

Activities

Collapse all

Employment (8)

University of Innsbruck: Innsbruck, AT

2011-10-01 to present | Head of the Opioid Research Group (Institute of Pharmacy)
Employment
Source: Self-asserted source
Mariana Spetea

Torrey Pines Institute for Molecular Studies: Port St. Lucie, FL, US

2014-07 to 2014-09 | Visiting Scientist
Employment
Source: Self-asserted source
Mariana Spetea

The Scripps Research Institute: Jupiter, FL, US

2013-07 to 2013-09 | Visiting Scientist
Employment
Source: Self-asserted source
Mariana Spetea

University of Innsbruck: Innsbruck, AT

2007-04-01 to 2011-09-30 | University Assistant (Institute of Pharmacy)
Employment
Source: Self-asserted source
Mariana Spetea

Semmelweis University: Budapest, HU

2004-09 to 2004-10 | Visiting Scientist (Faculty of Medicine)
Employment
Source: Self-asserted source
Mariana Spetea

Karolinska Institutet: Stockholm, SE

2002-04 to 2002-10 | Visiting Scientist (Department of Physiology and Pharmacology)
Employment
Source: Self-asserted source
Mariana Spetea

University of Innsbruck: Innsbruck, AT

2000-01-01 to 2002-09-30 | Senior Research Associate (Institute of Pharmacy)
Employment
Source: Self-asserted source
Mariana Spetea

Karolinska Institutet: Stockholm, SE

1998-01-01 to 1999-12-31 | Post-doctoral research fellow
Employment
Source: Self-asserted source
Mariana Spetea

Education and qualifications (3)

József Attila University: Szeged, HU

1994-09-01 to 1997-12-31 | Ph.D.
Education
Source: Self-asserted source
Mariana Spetea

Biological Research Center: Szeged, HU

1993-10-01 to 1994-09-30 | Scholarschip holder
Education
Source: Self-asserted source
Mariana Spetea

University of Bucharest: Bucharest, RO

1988-10-01 to 1993-07-01 | M.Sc.
Education
Source: Self-asserted source
Mariana Spetea

Professional activities (13)

International Association for the Study of Pain: Seattle, WA, US

2010-01-01 to present | Member
Membership
Source: Self-asserted source
Mariana Spetea

Federation of European Phamacological Societies: Amsterdam, NL

2008-01 to present | Member
Membership
Source: Self-asserted source
Mariana Spetea

Federation of European Neuroscience Societies: Brussels, BE

2001-01-01 to present | Member
Membership
Source: Self-asserted source
Mariana Spetea

University of Innsbruck: Innsbruck, AT

2015 | Research award
Distinction
Source: Self-asserted source
Mariana Spetea

International Narcotics Research Conference: Annapolis, MD, US

2005 | Travel award
Distinction
Source: Self-asserted source
Mariana Spetea

International Narcotics Research Conference: Kyoto, JP

2004 | Travel award
Distinction
Source: Self-asserted source
Mariana Spetea

Science4Life Venture Cup 2003: Frankfurt a. M, DE

2003 | Frist price (winner) in the Business Plan Competition
Distinction
Source: Self-asserted source
Mariana Spetea

Adventure X: Innsbruck, AT

2003 | Winner (third place) in the Business Plan Competition
Distinction
Source: Self-asserted source
Mariana Spetea

Best of Biotech (BOB): Vienna, AT

2001 | Award for the best business plan for Tirol (Austria)
Distinction
Source: Self-asserted source
Mariana Spetea

Wenner-Gren Foundations: Stockholm, SE

1999 | Research Felllowship Award
Distinction
Source: Self-asserted source
Mariana Spetea

Swedish Institute: Stockholm, SE

1998 | Research Felllowship Award
Distinction
Source: Self-asserted source
Mariana Spetea

Federation of European Biochemical Societies: Cambridge, GB

1998 | Travel award
Distinction
Source: Self-asserted source
Mariana Spetea

Hungarian Academy of Sciences: Szeged, HU

1993 | Scholarship Award
Distinction
Source: Self-asserted source
Mariana Spetea

Funding (8)

Safer analgesics by modulation of the kappa opioid receptor

2020 to 2025 | Grant
Austrian Science Fund (Vienna, AT)
GRANT_NUMBER:

I 4697
Source: Self-asserted source
Mariana Spetea

The kappa opioid system as target for the treatment of temporal lob epilepsy

2018-03 to 2023-03 | Grant
Austrian Science Fund (Vienna, AT)
Source: Self-asserted source
Mariana Spetea

Modulation of the kappa opioid system in TLE

2017-08 to 2022-08 | Grant
Austrian Science Fund (Vienna, AT)
Source: Self-asserted source
Mariana Spetea

Neuropeptide engineering for improved chronic pain treatment

2016-04 to 2021-06 | Grant
Austrian Science Fund (Vienna, AT)
Source: Self-asserted source
Mariana Spetea

Structure-Functional Activity Relationship Studies on Morphinans Interacting with the Mu Opioid Receptor

2016-01 to 2017-12 | Grant
Austrian Agency for International Mobility and Cooperation in Education, Science and Research (OEAD) (Vienna, AT)
Source: Self-asserted source
Mariana Spetea

The potential of targeting functional selectivity at the µ opioid receptor for the development of improved opioid analgesics

2015-04 to 2017-09 | Award
Aktion D. Swarovski KG 2014 (Innsbruck, AT)
Source: Self-asserted source
Mariana Spetea

Investigations on the functional selectivity of oxymorphone analogues and implications for the development of safer analgesics

2015-01 to 2016-12 | Grant
Tyrolean Research Fund (Innsbruck, AT)
Source: Self-asserted source
Mariana Spetea

New therapeutical streategies for gastrointestinal diseases

2011-06 to 2014-12 | Grant
Tyrolean Research Fund (Innsbruck, AT)
Source: Self-asserted source
Mariana Spetea

Peer review (30 reviews for 14 publications/grants)

Review activity for ACS chemical neuroscience. (2)
Review activity for ACS medicinal chemistry letters. (1)
Review activity for ACS omega. (2)
Review activity for Behavioural brain research. (1)
Review activity for Bioorganic chemistry. (1)
Review activity for Cellular and molecular life sciences (1)
Review activity for ChemMedChem. (1)
Review activity for European journal of medicinal chemistry. (1)
Review activity for European journal of pharmacology. (3)
Review activity for Journal of medicinal chemistry. (11)
Review activity for Neuropeptides (2)
Review activity for Neuroscience and biobehavioral reviews. (2)
Review activity for Pharmaceutics. (1)
Review activity for PloS one. (1)
How many people are using ORCID?